BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1352 related articles for article (PubMed ID: 15787744)

  • 1. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
    Cai Y; Tang XD; Zhou PJ
    Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anergic cells induced by the blockade of CD40-CD154 and CD28-B7 costimulatory pathways act as potent immunoregulatory cells in vitro and vivo.
    Cai Y; Zhou PJ; Tang XD
    Chin Med J (Engl); 2004 Aug; 117(8):1178-83. PubMed ID: 15361291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapamycin or tacrolimus alone fails to resist cardiac allograft accelerated rejection mediated by alloreactive CD4(+) memory T cells in mice.
    Liang H; Liao C; Qi Z; Sha C; Xie B; Chen J; Xia J; Wang Y; Yao Q; Zhao Y
    Transpl Immunol; 2010 Feb; 22(3-4):128-36. PubMed ID: 19755159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adoptive transfer of transplantation tolerance mediated by CD4+CD25+ and CD8+CD28- regulatory T cells induced by anti-donor-specific T-cell vaccination.
    Wang J; Zhang L; Tang J; Jiang S; Wang X
    Transplant Proc; 2008 Jun; 40(5):1612-7. PubMed ID: 18589160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combination of donor specific transfusion and rapamycin prolongs cardiac allograft survival in mice.
    Wu K; Xiang F; Yuan J; Zeng Z; Zhou H; Chang S; Chen ZK
    Transplant Proc; 2008 Dec; 40(10):3699-701. PubMed ID: 19100468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolongation of cardiac allograft survival by rapamycin and the invariant natural killer T cell glycolipid agonist OCH.
    Haeryfar SM; Lan Z; Leon-Ponte M; Duffy KR; Ge W; Liu W; Mele T; Garcia B; Wang H
    Transplantation; 2008 Aug; 86(3):460-8. PubMed ID: 18698251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histoincompatibility-associated differences in the phenotypes of murine cardiac allograft infiltrating T cells.
    Carlquist JF; Shelby J; Hammond EH; Greenwood JH; Anderson JL
    Immunology; 1994 May; 82(1):149-53. PubMed ID: 7913913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
    Otomo N; Motoyama K; Yu S; Shimizu Y; Margenthaler J; Tu F; Flye MW
    Surgery; 2000 Aug; 128(2):206-12. PubMed ID: 10922993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
    He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
    Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of regulatory T cells and indefinite survival of fully allogeneic cardiac grafts by ursodeoxycholic acid in mice.
    Zhang Q; Nakaki T; Iwami D; Niimi M; Shirasugi N
    Transplantation; 2009 Dec; 88(12):1360-70. PubMed ID: 20029332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic trioxide combined with co-stimulatory molecule blockade prolongs survival of cardiac allografts in alloantigen-primed mice.
    Xu S; Chen J; Wang F; Kang X; Lan T; Wang F; Li Z; Qi Z; Xing J
    Transpl Immunol; 2010 Oct; 24(1):57-63. PubMed ID: 20688163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anergic T cells generated in vitro suppress rejection response to islet allografts.
    Luo Z; Gotoh M; Grochowiecki T; Tanaka T; Kimura F; Kawashima H; Yagita H; Okumura K; Miyasaka M
    Transplantation; 2000 May; 69(10):2144-8. PubMed ID: 10852614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term limb allograft survival using a short course of anti-CD45RB monoclonal antibody, LF 15-0195, and rapamycin in a mouse model.
    Zhong T; Liu Y; Jiang J; Wang H; Temple CL; Sun H; Garcia B; Zhong R; Ross DC
    Transplantation; 2007 Dec; 84(12):1636-43. PubMed ID: 18165776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Free bone graft attenuates acute rejection and in combination with cyclosporin a leads to indefinite cardiac allograft survival.
    Wang H; Ge W; Arp J; Zassoko R; Liu W; Ichim TE; Jiang J; Jevnikar AM; Garcia B
    J Immunol; 2009 May; 182(10):5970-81. PubMed ID: 19414748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody treatment to prolong the secondary cardiac allograft survival in alloantigen-primed mice.
    Xie B; Chen J; Wang F; Lan T; Wang Y; Xia J; Li Z; Xie Q; Huang R; Qi Z
    Scand J Immunol; 2010 May; 71(5):345-52. PubMed ID: 20500685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of indefinite survival of fully allogeneic cardiac grafts and generation of regulatory cells by intratracheal delivery of alloantigens under blockade of the CD40 pathway.
    Uchida N; Shirasugi N; Akiyama Y; Matsumoto K; Shimazu M; Kitajima M; Hamano K; Aramaki O; Ikeda Y; Niimi M
    Transplantation; 2003 Mar; 75(6):878-84. PubMed ID: 12660518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of tolerance to skin allografts by intrathymic injection of donor splenocytes. Effect of donor-recipient strain combination and supplemental rapamycin.
    Dono K; Maki T; Wood ML; Monaco AP
    Transplantation; 1995 Dec; 60(11):1268-73. PubMed ID: 8525521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolongation of survival of fully allogeneic cardiac grafts and generation of regulatory cells by a histamine receptor 2 antagonist.
    Inoue F; Zhang Q; Akiyoshi T; Aramaki O; Iwami D; Matsumoto K; Kitagawa Y; Shirasugi N; Niimi M
    Transplantation; 2007 Nov; 84(10):1288-97. PubMed ID: 18049114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of (5R)-5-hydroxytriptolide (LLDT-8) on allograft rejection in full MHC-mismatched mouse cardiac transplantation.
    Tang W; Zhou R; Yang Y; Li YC; Yang YF; Zuo JP
    Transplantation; 2006 Mar; 81(6):927-33. PubMed ID: 16570019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 68.